Kamada Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Kamada Ltd
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Kamada Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Kamada Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Kamada Ltd is KMDA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Kamada Ltd has its primary listing on NASDAQ. You can trade Kamada Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Kamada Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Kamada Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Kamada Ltd.